Moderna

148,18 USD -3,92 (-2,58%)
Bid 147,77 USD
Ask 148,80 USD

Premiumpartner

Firmenbeschreibung

Moderna Inc. ist ein US amerikanisches Biotech-Unternehmen, das sich auf die Forschung und Entwicklung von Arzneimitteln auf Basis von mRNA spezialisiert. mRNA-Arzneien sind darauf ausgelegt, dass körpereigene Zellen Proteine mit therapeutischer oder vorbeugender Wirkung produzieren, die bei der Behandlung einer Vielzahl von Krankheiten helfen können. Die Anwendungsgebiete für mRNA-Produkte umfassen Therapeutika und Impfstoffe für Krebsimmuntherapien, seltene Krankheiten, Herz-Kreislauf-Erkrankungen, Autoimmunerkrankungen und Entzündungen. Die beständigen Fortschritte des Unternehmens in der Grundlagen- und angewandten mRNA-Forschung ermöglichen parallele Neuentwicklungen, sowohl unabhängig als auch mit strategischen Partnern zusammen. Es bestehen strategische Partnerschaften mit AstraZeneca PLC und Merck & Co., außerdem mit verschiedenen US-Behörden und Forschungseinrichtungen.

KeyData

endOfFinancialYear: 31.12.2022 00:00
stockholderStructure: Freefloat (74.9%),Baillie Gifford and Co. (11.4%),BlackRock, Inc. (6.9%),The Vanguard Group (6.8%)
sharesOutstanding: 384180469.0000
ceo: Stéphane Bancel
board: David Meline, Corinne Le Goff, Juan Andres, Kate Cronin, Marcello Damiani, Paul Burton, M.D., Shannon Thyme Klinger, Stephen Hoge, M.D., Tracey Franklin
supervisoryBoard: Dr. Noubar Afeyan, Elizabeth Nabel, M.D., Elizabeth Tallett, François Nader, M.D., Henri A. Termeer, Paul Sagan, Robert Langer, Sandra Horning, M.D., Stéphane Bancel, Stephen Berenson
countryID: 20
faceValue: 0.0001
faceValueCurrencyID: 4
faceValueCurrency: USD
sectorName: Biotechnologie
industryName: Biotechnologie
subsectorName: Biotechnologie
country: USA
countryName: USA

Kontakt

name: Lavina Talukdar
phone: +1-617-209-5834
email: IR@modernatx.com
irWebSite: https://investors.modernatx.com/

Adresse

street: 200 Technology Square
city: Cambridge, Massachusetts 02139, USA
phone: +1-617-714-6500
fax: +1-617-583-1998
webSite: https://www.modernatx.com/
email: info@modernatx.com

Finanzen (kurz)

year: 2020 cash: 2623.8500
balanceSheetTotal: 7336.7500 liabilities: 4775.3750
totalShareholdersEquity: 2561.3750 sales: 803.3950
investment: 24.7000 incomeBeforeTaxes: -744.5130
netIncome: -747.0640 cashFlow: 2388.2360
employees: 1300 currencyID: 4
units: 1000000 currency: USD
year: 2021 cash: 6848.0000
balanceSheetTotal: 24669.0000 liabilities: 10524.0000
totalShareholdersEquity: 14145.0000 sales: 18471.0000
investment: 18.0000 incomeBeforeTaxes: 13285.0000
netIncome: 12202.0000 cashFlow: 4224.0000
employees: 2700 currencyID: 4
units: 1000000 currency: USD
year: 2022 cash: 3205.0000
balanceSheetTotal: 25858.0000 liabilities: 6735.0000
totalShareholdersEquity: 19123.0000 sales: 19263.0000
incomeBeforeTaxes: 9575.0000 netIncome: 8362.0000
cashFlow: -3643.0000 currencyID: 4
units: 1000000 currency: USD

Finanzen (kurz)

year: 2020
cash: 2623.8500
balanceSheetTotal: 7336.7500
liabilities: 4775.3750
totalShareholdersEquity: 2561.3750
sales: 803.3950
investment: 24.7000
incomeBeforeTaxes: -744.5130
netIncome: -747.0640
cashFlow: 2388.2360
employees: 1300
currencyID: 4
units: 1000000
currency: USD
year: 2021
cash: 6848.0000
balanceSheetTotal: 24669.0000
liabilities: 10524.0000
totalShareholdersEquity: 14145.0000
sales: 18471.0000
investment: 18.0000
incomeBeforeTaxes: 13285.0000
netIncome: 12202.0000
cashFlow: 4224.0000
employees: 2700
currencyID: 4
units: 1000000
currency: USD
year: 2022
cash: 3205.0000
balanceSheetTotal: 25858.0000
liabilities: 6735.0000
totalShareholdersEquity: 19123.0000
sales: 19263.0000
incomeBeforeTaxes: 9575.0000
netIncome: 8362.0000
cashFlow: -3643.0000
currencyID: 4
units: 1000000
currency: USD

Finanzen (ausführlich)

year: 2021 units: 1000000
balanceSheetTotal: 24669.0000 cash: 6848.0000
currentAssets: 16071.0000 fixedAssets: 8598.0000
liabilities: 9128.0000 totalLiabilitiesEquity: 24669.0000
provisions: 1472.0000 totalShareholdersEquity: 14145.0000
employees: 2700 property: 1241.0000
longTermInvestments: 6843.0000 inventories: 1441.0000
accountsReceivable: 3175.0000 accountsPayable: 302.0000
liabilitiesTotal: 10524.0000 longTermDebt: 599.0000
sales: 18471.0000 netIncome: 12202.0000
operatingResult: 13296.0000 incomeInterest: 18.0000
investments: 1991.0000 incomeTaxes: 1083.0000
costGoodsSold: 2617.0000 grossProfit: 15854.0000
revenuePerEmployee: 6841111.1111 cashFlow: 13620.0000
cashFlowInvesting: -8523.0000 cashFlowFinancing: -873.0000
cashFlowTotal: 4224.0000 accountingStandard: US GAAP
equityRatio: 57.3392 debtEquityRatio: 74.4008
liquidityI: 75.0219 liquidityII: 109.8050
netMargin: 66.0603 grossMargin: 85.8318
cashFlowMargin: 73.7372 ebitMargin: 71.9831
ebitdaMargin: 0.0000 preTaxROE: 93.9201
preTaxROA: 53.8530 roe: 86.2637
roa: 49.4629 revenuesGrowth: 2199.1181
taxExpenseRate: 8.1521 equityTurnover: 1.3058
epsBasic: 30.3100 epsDiluted: 28.2900
incomeBeforeTaxes: 13285.0000 priceEarningsRatioCompany: 8.3794
priceCashFlowRatio: 7.5126 bookValuePerShare: 35.1103
marketCap: 102321680984.2800 earningsYield: 11.9340
cashFlowPerShare: 33.8072 priceBookValueRatio: 7.2338
priceEarningsRatio: 8.3856 netEarningsPerShare: 30.2875
currency: USD
year: 2022 units: 1000000
balanceSheetTotal: 25858.0000 cash: 3205.0000
currentAssets: 13431.0000 fixedAssets: 12427.0000
liabilities: 4923.0000 totalLiabilitiesEquity: 25858.0000
totalShareholdersEquity: 19123.0000 property: 2018.0000
longTermInvestments: 8318.0000 inventories: 949.0000
accountsReceivable: 1385.0000 accountsPayable: 487.0000
liabilitiesTotal: 6735.0000 longTermDebt: 912.0000
sales: 19263.0000 netIncome: 8362.0000
operatingResult: 9420.0000 incomeInterest: 200.0000
investments: 3295.0000 incomeTaxes: 1213.0000
costGoodsSold: 5416.0000 grossProfit: 13847.0000
cashFlow: 4981.0000 cashFlowInvesting: -5176.0000
cashFlowFinancing: -3448.0000 cashFlowTotal: -3643.0000
accountingStandard: US GAAP equityRatio: 73.9539
debtEquityRatio: 35.2194 liquidityI: 65.1026
liquidityII: 93.2358 netMargin: 43.4096
grossMargin: 71.8839 cashFlowMargin: 25.8579
ebitMargin: 48.9020 ebitdaMargin: 0.0000
preTaxROE: 50.0706 preTaxROA: 37.0292
roe: 43.7274 roa: 32.3382
netIncomeGrowth: -31.4703 revenuesGrowth: 4.2878
taxExpenseRate: 12.6684 equityTurnover: 1.0073
epsBasic: 21.2600 epsDiluted: 20.1200
epsBasicGrowth: -29.8581 incomeBeforeTaxes: 9575.0000
priceEarningsRatioCompany: 8.4487 priceCashFlowRatio: 13.9318
bookValuePerShare: 49.4979 marketCap: 69394317874.2800
earningsYield: 11.8361 pegRatio: -0.2830
cashFlowPerShare: 12.8928 priceBookValueRatio: 3.6288
priceEarningsRatio: 8.2988 netEarningsPerShare: 21.6442
currency: USD
year: 2023 priceEarningsRatioCompany: 7.2010
priceCashFlowRatio: 11.8744 bookValuePerShare: 49.4979
marketCap: 59146157901.9578 earningsYield: 13.8869
pegRatio: -0.2412 cashFlowPerShare: 12.8928
netAssetsPerShare: 49.4979 priceBookValueRatio: 3.0929
priceEarningsRatio: 7.0732 netEarningsPerShare: 21.6442
currency: USD

Finanzen (ausführlich)

year: 2021
units: 1000000
balanceSheetTotal: 24669.0000
cash: 6848.0000
currentAssets: 16071.0000
fixedAssets: 8598.0000
liabilities: 9128.0000
totalLiabilitiesEquity: 24669.0000
provisions: 1472.0000
totalShareholdersEquity: 14145.0000
employees: 2700
property: 1241.0000
longTermInvestments: 6843.0000
inventories: 1441.0000
accountsReceivable: 3175.0000
accountsPayable: 302.0000
liabilitiesTotal: 10524.0000
longTermDebt: 599.0000
sales: 18471.0000
netIncome: 12202.0000
operatingResult: 13296.0000
incomeInterest: 18.0000
investments: 1991.0000
incomeTaxes: 1083.0000
costGoodsSold: 2617.0000
grossProfit: 15854.0000
revenuePerEmployee: 6841111.1111
cashFlow: 13620.0000
cashFlowInvesting: -8523.0000
cashFlowFinancing: -873.0000
cashFlowTotal: 4224.0000
accountingStandard: US GAAP
equityRatio: 57.3392
debtEquityRatio: 74.4008
liquidityI: 75.0219
liquidityII: 109.8050
netMargin: 66.0603
grossMargin: 85.8318
cashFlowMargin: 73.7372
ebitMargin: 71.9831
ebitdaMargin: 0.0000
preTaxROE: 93.9201
preTaxROA: 53.8530
roe: 86.2637
roa: 49.4629
revenuesGrowth: 2199.1181
taxExpenseRate: 8.1521
equityTurnover: 1.3058
epsBasic: 30.3100
epsDiluted: 28.2900
incomeBeforeTaxes: 13285.0000
priceEarningsRatioCompany: 8.3794
priceCashFlowRatio: 7.5126
bookValuePerShare: 35.1103
marketCap: 102321680984.2800
earningsYield: 11.9340
cashFlowPerShare: 33.8072
priceBookValueRatio: 7.2338
priceEarningsRatio: 8.3856
netEarningsPerShare: 30.2875
currency: USD
year: 2022
units: 1000000
balanceSheetTotal: 25858.0000
cash: 3205.0000
currentAssets: 13431.0000
fixedAssets: 12427.0000
liabilities: 4923.0000
totalLiabilitiesEquity: 25858.0000
totalShareholdersEquity: 19123.0000
property: 2018.0000
longTermInvestments: 8318.0000
inventories: 949.0000
accountsReceivable: 1385.0000
accountsPayable: 487.0000
liabilitiesTotal: 6735.0000
longTermDebt: 912.0000
sales: 19263.0000
netIncome: 8362.0000
operatingResult: 9420.0000
incomeInterest: 200.0000
investments: 3295.0000
incomeTaxes: 1213.0000
costGoodsSold: 5416.0000
grossProfit: 13847.0000
cashFlow: 4981.0000
cashFlowInvesting: -5176.0000
cashFlowFinancing: -3448.0000
cashFlowTotal: -3643.0000
accountingStandard: US GAAP
equityRatio: 73.9539
debtEquityRatio: 35.2194
liquidityI: 65.1026
liquidityII: 93.2358
netMargin: 43.4096
grossMargin: 71.8839
cashFlowMargin: 25.8579
ebitMargin: 48.9020
ebitdaMargin: 0.0000
preTaxROE: 50.0706
preTaxROA: 37.0292
roe: 43.7274
roa: 32.3382
netIncomeGrowth: -31.4703
revenuesGrowth: 4.2878
taxExpenseRate: 12.6684
equityTurnover: 1.0073
epsBasic: 21.2600
epsDiluted: 20.1200
epsBasicGrowth: -29.8581
incomeBeforeTaxes: 9575.0000
priceEarningsRatioCompany: 8.4487
priceCashFlowRatio: 13.9318
bookValuePerShare: 49.4979
marketCap: 69394317874.2800
earningsYield: 11.8361
pegRatio: -0.2830
cashFlowPerShare: 12.8928
priceBookValueRatio: 3.6288
priceEarningsRatio: 8.2988
netEarningsPerShare: 21.6442
currency: USD
year: 2023
priceEarningsRatioCompany: 7.2010
priceCashFlowRatio: 11.8744
bookValuePerShare: 49.4979
marketCap: 59146157901.9578
earningsYield: 13.8869
pegRatio: -0.2412
cashFlowPerShare: 12.8928
netAssetsPerShare: 49.4979
priceBookValueRatio: 3.0929
priceEarningsRatio: 7.0732
netEarningsPerShare: 21.6442
currency: USD